Archive

Nissho saw sales rise only 1% to ¥17 billion ($930 million) in the year to March 1997. The Japanese company's net income was Yen3 billion, compared with Yen1.7 billion for the previous year, reports Reuters. Nissho produces disposable medical equipment.

A pilot partnership between the FDA and Canada's Medical Devices Programme has been so successful the two agencies will talk this week about how to expand it.

Purchasing of upgraded or enhanced durable medical equipment would be simplified under the Medicare bill unanimously approved by the Senate Finance Committee June 18. The provision would make it easier for beneficiaries to buy higher-end DME by incurring only the difference in cost between the upgrade and the standard model as an out-of-pocket expense, with DME suppliers being reimbursed for the cost of the standard item.

A computer-assisted surgical navigation system for use during total hip replacement surgery has been developed by Carnegie Mellon University and Shadyside Hospital in the US.

Innogenetics has launched its INNO-LIA ANA test for detecting autoimmune rheumatological disease. Autoimmune disorders, in which the body mistakenly attacks itself, are responsible for a large number of rheumatological diseases. The Belgian company estimates that in Europe alone autoimmune diseases affect as many as three million people, mostly women.

Millenium Biologix is to develop and commercialise Allelix Biopharmaceuticals' bone cell stimulating factor for medical device and implant applications. Millenium, based in Kingston, Ontario, Canada, says that the agent will complement its synthetic bone implants, which are able to promote new bone formation and remodelling.

US company Biometric Imaging has elected a former group vice-president of Baxter International, Dale Smith, to its board of directors.

Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.

In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.

A panel of mental health experts, advocates, and patients met recently in Manhattan to discuss the promise of the Neuronetics’ NeuroStar transcranial magnetic stimulation system, which the US FDA recently cleared to treat depression in adolescents ages 15 through 21. It is the first and only treatment of its kind the regulatory agency has cleared for this patient group.

Anne Osdoit has learned how to transform what would be challenges in her career into sources of inspiration. With this vital skill, she has not only led her company, Moon Surgical, to success, but also aided Sofinnova, where she serves as partner, in its investment strategy.

Fibroids are an issue that can be debilitating for women, however funding of new treatments for them is abysmal. Medtech Insight spoke to Chung Looi, CEO of Ablatus, about this valuable market, and why women’s health is so often overlooked, and how its solution could have an impact. 

Alison Sundset heads up Holocare, a company working to transform surgical planning. Over the course of her career, she has had to train herself not to show emotions at certain times - an issue she argues would not have presented itself if she was a man.  

Abbott’s weaker rapid diagnostic sales see the erstwhile industry leader slip down the global 2023 medtech rankings, while Johnson & Johnson passes it on the way up on the back of strong external and internal growth.

Sigrid Therapeutics co-founder and CEO Sana Alajmovic took time out of what's been an "exciting" year for the company, which makes silica-based products to treat diabetes and related conditions, to speak with Medtech Insight about her experiences as a Bosnia-born working mom in Sweden. This article is the first in a series for International Women's Day.

Introducing the all-new Citeline News and Insights app, providing seamless access to all your favorite award-winning publications. Explore the latest articles from Pink Sheet, Scrip, In Vivo, Medtech Insight, Generics Bulletin and HBW Insight, all in one stylish, intuitive and user-friendly platform.

AI voice tech start-up Canary Speech is developing algorithmic models for detecting behavioral health, progressive neurological and cognitive diseases based on a 40-second recording of speech. Medtech Insight caught up with Canary CEO Henry O’Connell at DHIS West to learn more about the company and its plans.

Ochre Bio co-founder and CEO, Jack O’Meara, spoke to Medtech Insight about the company’s human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how a fledgling drug company's early work can mirror that seen in diagnostics.

The closed loop system market is getting busier and busier; however ViCentra is hoping that its Kaleido system, one of the smallest pumps available, will be differentiated enough to secure market share.

Phenomix has developed a saliva-based genetic test that could be used to infer what “type” of obesity a patient suffers from, giving clinicians insights into which drugs are best prescribed.